A Prospective, Multicenter, Randomized Controlled Study of Etoposide, Cytarabine Combined With Pegfilgrastim vs. Cyclophosphamide Combined With G-CSF for Hematopoietic Stem Cell Mobilization in Newly Diagnosed Multiple Myeloma Patients.

This document provides information about a clinical trial for patients with multiple myeloma who require autologous stem cell transplantation (ASCT). The trial compares two treatment regimens: the CG regimen, which combines cyclophosphamide and G-CSF, and the EAP regimen, which combines etoposide, cytarabine, and PEG-rhG-CSF. The trial is currently recruiting participants in China and aims to enroll a total of 99 patients. The document also includes eligibility criteria and contact information for the study. [Extracted from the article]